Table 6.

Change in serum creatinine for patients who experienced a renal failure AE (n = 8)

Patient	Serum creatinine (mg/dL)			Days elapsed
	Baseline	Last recorded value	Increase from baseline
1	1.1	11.1	10	33
2	1.8	2.5	0.7	49
3	0.3	1.4	1.1	15
4	2.6	2.9	0.3	15
5	1.8	2.3	0.5	12
6	1.2	3.3	2.1	11
7	1.0	1.4	0.4	45
8	1.7	5.8	4.1	13

Of 12 patients with bacteremia or endocarditis who experienced renal failure during telavancin therapy, two did not have CrCl measurements recorded as they were on dialysis at baseline and two were missing a baseline serum creatinine concentration

AE adverse event, CrCL creatinine clearance